🇺🇸 FDA
Patent

US 7956054

Dual-acting pyrazole antihypertensive agents

granted A61PA61P13/00A61P13/12

Quick answer

US patent 7956054 (Dual-acting pyrazole antihypertensive agents) held by Theravance, Inc. expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P13/00, A61P13/12, A61P29/00, A61P3/06